Virtu Financial’s MAIA Biotechnology MAIA Stock Holding History

Virtu Financial’s Portfolio MAIA Stock Details MAIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-32,487	Closed	-$71K	–	1642
2024 Q1	$71K	Buy	+32,487	New	+$48.7K	0.01%	972

Other funds holding MAIA

HFF

Halter Ferguson Financial Carmel, Indiana $456M AUM 49.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CWM

Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Naviter Wealth Little Rock, Arkansas $801M AUM 22.2% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Virtu Financial's MAIA Position: Q2 2024 in Review

Virtu Financial sold out of MAIA Biotechnology (MAIA) in Q2 2024, closing a stake of 32,487 shares — an estimated $71K sold.

Virtu Financial first reported a position in MAIA in Q1 2024 and held it in 1 quarter. The position peaked at $71K in Q1 2024. 21 funds tracked by Wall St. Rank hold MAIA as of Q2 2024.

Virtu Financial reported no remaining MAIA Biotechnology position as of Q2 2024 after selling out during the quarter.
Virtu Financial sold 32,487 MAIA Biotechnology shares in Q2 2024, an estimated $71K.
Virtu Financial first reported a position in MAIA Biotechnology in Q1 2024 and held it in 1 quarter.
Virtu Financial's MAIA Biotechnology position peaked at $71K in Q1 2024.
21 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2024.

Based on Virtu Financial's 13F filing for Q2 2024, filed 9 Aug 2024.